{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:49:52Z","timestamp":1778698192797,"version":"3.51.4"},"reference-count":10,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":11534,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1981,8,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Systemic \u0394<jats:sup>9<\/jats:sup>\u2010tetrahydrocannabinol (THC), administered either by smoking marihuana or as synthetic THC in soft gelatin capsules, lowers ocular tension in various glaucomas, but at the expense of significant decreases in systolic blood pressure. Topical THC in light mineral oil vehicles, though effective in laboratory animals, was not shown effective in 0.05 and 0.1% topical solutions when administered to six subjects with primary open\u2010angle glaucoma in a randomized, balanced, double\u2010masked protocol. Light mineral oil, which has an affinity for corneal epithelium, is an optimum vehicle for administering drugs whose mechanisms of action are systemic rather than local within the eye. Further glaucoma research should therefore proceed with marihuanas containing insignificant levels of THC (less than 0.4%) and with various local delivery systems of the ocular\u2010active cannabinoid found in <jats:italic>Cannabis sativa<\/jats:italic>.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1981.tb02626.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T01:35:12Z","timestamp":1362792912000},"source":"Crossref","is-referenced-by-count":53,"title":["Topical \u0394<sup>9<\/sup>\u2010Tetrahydrocannabinol and Aqueous Dynamics in Glaucoma"],"prefix":"10.1002","volume":"21","author":[{"given":"JOHN C.","family":"MERRITT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DWIGHT D.","family":"PERRY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID N.","family":"RUSSELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BRENDA F.","family":"JONES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"191","article-title":"Effects of tetrahydrocannabinol on arterial and intraocular hypertension","volume":"17","author":"Crawford WJ","year":"1979","journal-title":"Int J Clin Pharm Biopharm."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(80)35258-5"},{"key":"e_1_2_1_4_2","first-page":"45","article-title":"Effect of marihuana inhalation on the intraocular pressure and blood pressure in open angle glaucoma","volume":"86","author":"Merritt JC","year":"1979","journal-title":"Ophthalmology."},{"key":"e_1_2_1_5_2","first-page":"253","article-title":"Diurnal intraocular pressure in juvenile open\u2010angle glaucoma","volume":"11","author":"Merritt JC","year":"1979","journal-title":"Ann Ophthalmol."},{"key":"e_1_2_1_6_2","article-title":"Effect of topical \u03949\u2010tetrahydrocannabinol in hypertensive glaucoma","author":"Merritt JC","journal-title":"J Pharm Pharmacol."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(77)90260-3"},{"key":"e_1_2_1_8_2","article-title":"Effect of topical \u03949\u2010tetrahydrocannabinol on intraocular pressure in dogs","author":"Merritt JC","journal-title":"Glaucoma."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(78)90048-8"},{"key":"e_1_2_1_10_2","first-page":"947","article-title":"Oral \u03949\u2010tetrahydrocannabinol in heterogeneous glaucomas","volume":"12","author":"Merritt JC","year":"1980","journal-title":"Ann Ophthalmol."},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(76)90173-1"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1981.tb02626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1981.tb02626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:47:58Z","timestamp":1694584078000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1981.tb02626.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,8,9]]},"references-count":10,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1981,8,9]]}},"alternative-id":["10.1002\/j.1552-4604.1981.tb02626.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1981.tb02626.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,8,9]]}}}